HSA Approves "Spikevax" as the New Brand Name for Moderna's COVID-19 Vaccine

The Health Sciences Authority (HSA) has on 14 September 2021 approved the application by Moderna to introduce the brand name “Spikevax” for its COVID-19 vaccine currently authorised under the Pandemic Special Access Route. There are no changes to the vaccine and its quality, safety and efficacy.

HEALTH SCIENCES AUTHORITY
SINGAPORE
14 SEPTEMBER 2021